01863cam a2200385 a 45000010006000000050017000060080041000230100017000640350023000810400049001040160018001530200033001710200036002040200031002400200034002710350020003050500024003250600015003490600028003640820017003921000034004092450108004432600035005513000029005864900030006155040051006455050564006966500019012606500027012796500029013066500030013356500036013656500033014018300043014347552420230411085733.0950615s1995    txua     b    001 0 eng    a   95032203   a(OCoLC)ocm32820182  aDNLM/DLCcDLCdNLMdBTCTAdYDXCPdOCLCGdZCH7 a95096492DNLM  a1570592861 (U.S. and Canada)  a9781570592867 (U.S. and Canada)  a3540600345 (International)  a9783540600343 (International)  a(OCoLC)3282018214aRC632.C26bW56 199500a1996 E-68410aWD 200.5.C2bW757h 199500a616.3/992201 aWimalawansa, Sunil J.,d1952-10aHypercalcemia of malignancy :betiology, pathogenesis, and clinical management /cSunil J. Wimalawansa.  aAustin :bR.G. Landes,cc1995.  a201 p. :bill. ;c26 cm.1 aMedical intelligence unit  aIncludes bibliographical references and index.00tForeword /rGregory R. Mundy and Cary W. Cooper --g1.tHypercalcemia of Malignancy --g2.tHomeostasis of Extracellular Calcium Concentration --g3.tDiagnosis and Differential Diagnosis of Hypercalcemia --g4.tHomeostatic Factors Regulating Hypercalcemia of Malignancy --g5.tPathophysiology of Hypercalcemia of Malignancy --g6.tTreatment of Hypercalcemia of Malignancy --g7.tSpecific Therapeutic Agents --g8.tCalcitonin, Corticosteroids and Plicamycin --g9.tPhosphate, Prostaglandin Inhibitors, Gallium Nitrate and Other Novel Therapeutic Agents. 0aHypercalcemia. 0aCancerxComplications.12aHypercalcemiaxetiology.12aNeoplasmsxcomplications.12aHypercalcemiaxphysiopathology.22aHypercalcemiaxdrug therapy. 0aMedical intelligence unit (Unnumbered)